Company / Revenue per Share
Fulgent Genetics, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$10.46
FY2025
5-year range
$1.15 / $33.72
FY2021-FY2025
Trend
+9.4%
vs FY2024
Sector context
#115 of 153
Health Care
What the data says
Fulgent Genetics, Inc.'s revenue per share of $10.46 is lower than 75% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 10 years, ranging from $0.07 in FY2016 to $33.72 in FY2023.
Based on SEC 10-K filings.
10.46 in FY2025 with a 5-year CAGR of -11.8%.
Declined from $33.72 to $10.46 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -9.2%
- 5-Year CAGR
- -11.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 153This company $10.46 Sector average $123.62
▼
-91.5% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 9.4% year-over-year.
- Ranks #115 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.46 | +9.4% |
| FY2024 | $9.56 | -71.6% |
| FY2023 | $33.72 | +141.1% |
| FY2022 | $13.98 | +1111.3% |
| FY2021 | $1.15 | -94.1% |
| FY2020 | $19.63 | +1570.7% |
| FY2019 | $1.17 | +12.0% |
| FY2018 | $1.05 | +249.6% |
| FY2017 | $0.30 | +315.2% |
| FY2016 | $0.07 | -91.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026